ALEFACEPT

Approval Year

Substance Class	Protein
Protein Type	FC FUSION PROTEIN
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	ELK3V90G6C
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ALEFACEPT

Official Name

English

ALEFACEPT [MART.]

Common Name

English

AMEVIVE

Brand Name

English

ALEFACEPT [MI]

Common Name

English

RECOMBINANT HUMAN LFA-3/IGG.SUB(1). FUSION PROTEIN

Common Name

English

Showing 1 to 5 of 19 entries

Previous1 2 3 4Next

Show entries

Classification Tree

Code System

Code

Established Pharmacologic Class

NDF-RT

N0000175859

Selective immunosuppressants

WHO-VATC

QL04AA15

Psoriasis

LIVERTOX

NBK548345

Antibodies

NDF-RT

N0000169367

Antibodies

NDF-RT

N0000169367

Showing 1 to 5 of 11 entries

Previous1 2 3Next

Show entries

Code System

Code

Type

Description

FDA UNII

ELK3V90G6C

PRIMARY

INN

8059

PRIMARY

EVMPD

SUB20562

PRIMARY

WIKIPEDIA

ALEFACEPT

PRIMARY

DRUG CENTRAL

5088

PRIMARY

Showing 1 to 5 of 14 entries

Previous1 2 3Next

Subunit 0

Subunit 1

Show entries

Related Record

Type

Details


					ZU51KFJ7F3

CD2

TARGET -> INHIBITOR


					JA0XKI4FW7

HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I

TARGET -> AGONIST

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Related Record

Type

Details


					ELK3V90G6C

ALEFACEPT

ACTIVE MOIETY

Showing 1 to 1 of 1 entries

Previous1Next

Name	Property Type	Amount
Biological Half-life	PHARMACOKINETIC	270 hours (average)

Molecular Formula	CHEMICAL	ESTIMATED C3264H4978N840O988S20
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 72500 Da (average)